Terms: = Head and neck cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Treatment
124 results:
1. cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2.
Liu F; Tang L; Liu H; Chen Y; Xiao T; Gu W; Yang H; Wang H; Chen P
Cell Death Dis; 2024 Apr; 15(4):279. PubMed ID: 38637504
[TBL] [Abstract] [Full Text] [Related]
2. [Clinicopathological and molecular characteristics of esophageal carcinoma with ductal differentiation: analysis of 17 cases].
Jiang WJ; Ao S; Cui YY; Lu L; Wang CN
Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):276-281. PubMed ID: 38433056
[No Abstract] [Full Text] [Related]
3. Targeting nrf2 to treat thyroid cancer.
Gong Z; Xue L; Li H; Fan S; van Hasselt CA; Li D; Zeng X; Tong MCF; Chen GG
Biomed Pharmacother; 2024 Apr; 173():116324. PubMed ID: 38422655
[TBL] [Abstract] [Full Text] [Related]
4. Quantitative US Delta Radiomics to Predict Radiation Response in Individuals with head and neck Squamous Cell Carcinoma.
Osapoetra LO; Dasgupta A; DiCenzo D; Fatima K; Quiaoit K; Saifuddin M; Karam I; Poon I; Husain Z; Tran WT; Sannachi L; Czarnota GJ
Radiol Imaging Cancer; 2024 Mar; 6(2):e230029. PubMed ID: 38391311
[TBL] [Abstract] [Full Text] [Related]
5. CTC together with Shh and nrf2 are prospective diagnostic markers for HNSCC.
Rahman MM; Hossain MM; Islam S; Ahmed R; Majumder M; Dey S; Kawser M; Sarkar B; Himu MER; Chowdhury AA; Ahmed S; Biswas S; Anwar MM; Hussain MJ; Kumar Shil R; Baidya S; Parial R; Islam MM; Bharde A; Jayant S; Aland G; Khandare J; Uddin SB; Noman ASM
BMC Mol Cell Biol; 2024 Feb; 25(1):4. PubMed ID: 38336617
[TBL] [Abstract] [Full Text] [Related]
6. CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma.
Li Y; Yang C; Xie L; Shi F; Tang M; Luo X; Liu N; Hu X; Zhu Y; Bode AM; Gao Q; Zhou J; Fan J; Li X; Cao Y
Cell Death Dis; 2024 Jan; 15(1):95. PubMed ID: 38287022
[TBL] [Abstract] [Full Text] [Related]
7. Piperlongumine inhibits esophageal squamous cell carcinoma in vitro and in vivo by triggering nrf2/ROS/TXNIP/NLRP3-dependent pyroptosis.
Cui Y; Chen XB; Liu Y; Wang Q; Tang J; Chen MJ
Chem Biol Interact; 2024 Feb; 390():110875. PubMed ID: 38242274
[TBL] [Abstract] [Full Text] [Related]
8. Uncovering immune checkpoint heterogeneity in oral squamous cell carcinoma using single cell RNA-sequencing data highlights three subgroups of patients with distinct immune phenotypes.
Le Meitour Y; Foy JP; Guinand M; Michon L; Karabajakian A; Fayette J; Saintigny P; Mahtouk K
Oral Oncol; 2024 Feb; 149():106680. PubMed ID: 38218022
[TBL] [Abstract] [Full Text] [Related]
9. MiR-630 Promotes Radioresistance by Induction of Anti-Apoptotic Effect via nrf2-GPX2 Molecular Axis in head-neck cancer.
You GR; Cheng AJ; Shen EY; Fan KH; Huang YF; Huang YC; Chang KP; Chang JT
Cells; 2023 Dec; 12(24):. PubMed ID: 38132173
[TBL] [Abstract] [Full Text] [Related]
10. Identification of prognostic value of anoikis-related gene score model combined with tumor microenvironment score models in esophageal squamous cell carcinoma.
Zhang M; Liang Y; Song P
J Gene Med; 2024 Jan; 26(1):e3624. PubMed ID: 38087999
[TBL] [Abstract] [Full Text] [Related]
11. RASSF1A promotes radiosensitivity in nasopharyngeal carcinoma by promoting FoxO3a and inhibiting the nrf2/TXNRD1 signaling pathway.
Si Y; Meng L; Zhang B; Wu Y; Du Q; Xu J; Qi J
Neoplasma; 2023 Oct; 70(5):633-644. PubMed ID: 38053374
[TBL] [Abstract] [Full Text] [Related]
12. Near-infrared-responsive GE11-CuS@Gal nanoparticles as an intelligent drug release system for targeting therapy against oral squamous cell carcinoma.
Lan Q; Wang S; Chen Z; Hua J; Hu J; Luo S; Xu Y
Int J Pharm; 2024 Jan; 649():123667. PubMed ID: 38048890
[TBL] [Abstract] [Full Text] [Related]
13. Long non-coding RNA NMRAL2P promotes glycolysis and reduces ROS in head and neck tumors by interacting with the ENO1 protein and promoting GPX2 transcription.
Nie Q; Cao H; Yang J; Liu T; Wang B
PeerJ; 2023; 11():e16140. PubMed ID: 37810778
[TBL] [Abstract] [Full Text] [Related]
14. Small molecule screen identifies pyrimethamine as an inhibitor of nrf2-driven esophageal hyperplasia.
Paiboonrungruang C; Xiong Z; Lamson D; Li Y; Bowman B; Chembo J; Huang C; Li J; Livingston EW; Frank JE; Chen V; Li Y; Weissman B; Yuan H; Williams KP; Ben Major M; Chen X
Redox Biol; 2023 Nov; 67():102901. PubMed ID: 37776708
[TBL] [Abstract] [Full Text] [Related]
15. Circulating Tumor DNA Dynamics as Prognostic Markers in Locally Advanced and Metastatic Esophageal Squamous Cell Carcinoma.
Ng HY; Ko JMY; Lam KO; Kwong DLW; Lo AWI; Wong IYH; Wong CLY; Chan SY; Chan KK; Law TT; Dai W; Fong HCH; Choy FSF; Lo CK; Chen C; Law SYK; Lung ML
JAMA Surg; 2023 Nov; 158(11):1141-1150. PubMed ID: 37728901
[TBL] [Abstract] [Full Text] [Related]
16. Targeted Proteomic Quantitation of nrf2 Signaling and Predictive Biomarkers in HNSCC.
Wamsley NT; Wilkerson EM; Guan L; LaPak KM; Schrank TP; Holmes BJ; Sprung RW; Gilmore PE; Gerndt SP; Jackson RS; Paniello RC; Pipkorn P; Puram SV; Rich JT; Townsend RR; Zevallos JP; Zolkind P; Le QT; Goldfarb D; Major MB
Mol Cell Proteomics; 2023 Nov; 22(11):100647. PubMed ID: 37716475
[TBL] [Abstract] [Full Text] [Related]
17. TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/nrf2 signaling.
Xu T; Yang Y; Chen Z; Wang J; Wang X; Zheng Y; Wang C; Wang Y; Zhu Z; Ding X; Zhou J; Li G; Zhang H; Zhang W; Wu Y; Song X
J Exp Clin Cancer Res; 2023 Aug; 42(1):190. PubMed ID: 37525222
[TBL] [Abstract] [Full Text] [Related]
18. Human papillomavirus-driven repression of nrf2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma.
Ramesh PS; Bovilla VR; Swamy VH; Manoli NN; Dasegowda KB; Siddegowda SM; Chandrashekarappa S; Somasundara VM; Kabekkodu SP; Rajesh R; Devegowda D; Thimmulappa RK
Free Radic Biol Med; 2023 Aug; 205():234-243. PubMed ID: 37328018
[TBL] [Abstract] [Full Text] [Related]
19. Potential inhibitors of RPS6KB2 and nrf2 in head and neck squamous cell carcinoma.
Madhukar G; Subbarao N
J Biomol Struct Dyn; 2024; 42(4):1875-1900. PubMed ID: 37160694
[TBL] [Abstract] [Full Text] [Related]
20. Daidzein attenuated paclitaxel-induced neuropathic pain via the down-regulation of TRPV1/P2Y and up-regulation of nrf2/HO-1 signaling.
Zafar S; Luo Y; Zhang L; Li CH; Khan A; Khan MI; Shah K; Seo EK; Wang F; Khan S
Inflammopharmacology; 2023 Aug; 31(4):1977-1992. PubMed ID: 37145202
[TBL] [Abstract] [Full Text] [Related]
[Next]
